Chinese Medicine Maker Announces Clinical Trial in Singapore
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
What happened
Wang Lei, chairman of Tianjin Pharmaceutical Group, hosted the 23rd World Congress of Chinese Medicine in Singapore on October 19, 2026. During the event, Da Ren Tang announced a collaboration with Singapore General Hospital to conduct an international randomized, double-blind, controlled trial of its heart remedy, Suxiao Jiuxin Pills.
From vietnamnews.vn
Why it matters
The study marks the first time a Chinese proprietary medicine has undergone clinical trials at a major Western-medicine hospital in Singapore. Wang Lei noted that the holistic approach of Chinese medicine could offer an advantage in strengthening public health systems.
From vietnamnews.vn
Who's involved
- Wang LeiHosted the World Congress and announced the international clinical trial collaboration.
- SingaporeLocation where the World Congress was held.
- Singapore General HospitalPartnering with Da Ren Tang to conduct the international clinical trial.
Keep exploring
The entities involved
-
Wang Lei
Chinese actor
Nothing else this week.
-
Singapore
sovereign island country and city-state in maritime Southeast Asia
-
World Federation of Chinese Medicine Societies
non-governmental organization in China
Related events
- Singapore PM Lawrence Wong spoke to reporters in Beijing on November 21, 2026.
- High-level diplomatic engagements occurred between China and Singapore, including visits by Xi Jinping and Li Qiang.
- A multi-national summit was held in Singapore involving participants from the Philippines, Malaysia, and Japan.
- Singapore's Lawrence Wong attended the APEC summit in Shenzhen, where Singapore discussed cooperation with China and participated in trilateral meetings including Russia.